Intraocular Cytokines in Non-responders to Ranibizumab Treatment for Neovascular AMD

Clinical trial NCT02218177 · COMPLETED

Trial details

NCT number: NCT02218177
Sponsor: University Health Network, Toronto
Status: COMPLETED
Study type: OBSERVATIONAL

Age Related Macular Degeneration

Start date: 2014-08-01
Primary completion: 2016-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.